Codexis Announces Agreement with Pfizer to Supply Enzyme for the Manufacture of PAXLOVID (nirmatrelvir tablets; ritonavir tablets)
14.07.2022 - REDWOOD CITY, Calif., July 14, 2022 (GLOBE NEWSWIRE) - Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that the Company has entered into an agreement with Pfizer for the ...
Source: wallstreet-online.de